Piper Sandler & Co’s Exelixis EXEL Stock Holding History

Piper Sandler & Co’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-25,000	Closed	-$89K	–	129
2014 Q1	$89K	Buy	+25,000	New	+$170K	0.08%	87

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Piper Sandler & Co's EXEL Position: Q2 2014 in Review

Piper Sandler & Co sold out of Exelixis (EXEL) in Q2 2014, closing a stake of 25,000 shares — an estimated $89K sold.

Piper Sandler & Co first reported a position in EXEL in Q1 2014 and held it in 1 quarter. The position peaked at $89K in Q1 2014. 136 funds tracked by Wall St. Rank hold EXEL as of Q2 2014.

Piper Sandler & Co reported no remaining Exelixis position as of Q2 2014 after selling out during the quarter.
Piper Sandler & Co sold 25,000 Exelixis shares in Q2 2014, an estimated $89K.
Piper Sandler & Co first reported a position in Exelixis in Q1 2014 and held it in 1 quarter.
Piper Sandler & Co's Exelixis position peaked at $89K in Q1 2014.
136 funds tracked by Wall St. Rank held Exelixis as of Q2 2014.

Based on Piper Sandler & Co's 13F filing for Q2 2014, filed 14 Aug 2014.